[1] |
樊东升, 陈璐. 糖尿病周围神经病[J]. 中华神经科杂志, 2023,56(7): 814-819. DOI: 10.3760/cma.j.cn113694-20230216-00101.Fan DS, Chen L. Diabetic peripheral neuropathy[J]. Chin J Neurol,2023, 56(7): 814-819. DOI: 10.3760/cma.j.cn113694-20230216-00101.
|
[2] |
Elafros MA, Andersen H, Bennett DL, et al. Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis,and new treatments[J]. Lancet Neurol, 2022, 21(10): 922-936. DOI:10.1016/s1474-4422(22)00188-0.
|
[3] |
中华医学会糖尿病学分会神经并发症学组. 糖尿病神经病变诊治专家共识(2021年版)[J]. 中华糖尿病杂志, 2021, 13(6): 540-557. DOI: 10.3760/cma.j.cn115791-20210310-00143.Branch Group of Neurological Complications, Chinese Diabetes Society. Expert consensus on diagnosis and treatment of diabetic neuropathy (2021 edition)[J]. Chin J Diabetes Mellitus, 2021, 13(6): 540-557. DOI: 10.3760/cma.j.cn115791-20210310-00143.
|
[4] |
黄海伦, 吴珊. 糖尿病周围神经病相关发病机制研究进展[J].中华脑科疾病与康复杂志(电子版), 2019, 9(3): 176-180. DOI:10.3877/cma.j.issn.2095-123X.2019.03.012.Huang HL, Wu S. Research progress on the pathogenesis of diabetic peripheral neuropathy[J]. Chin J Brain Dis Rehabil(Electronic Edition),2019, 9(3): 176-180. DOI: 10.3877/cma.j.issn.2095-123X.2019.03.012.
|
[5] |
赵娜, 谢晨, 杨文佳, 等. 中枢五羟色胺与睡眠-觉醒[J]. 脑与神经疾病杂志, 2023, 31(7): 454-458.Zhao N, Xie C, Yang WJ, et al. Central 5-HT and sleep-wake[J].Journal of Brain and Nervous Diseases, 2023, 31(7): 454-458.
|
[6] |
Irving H, Turek I, Kettle C, et al. Tapping into 5-HT3 receptors to modify metabolic and immune responses[J]. Int J Mol Sci, 2021,22(21): 11910. DOI: 10.3390/ijms222111910.
|
[7] |
Chen Y, Liu Y, Song Y, et al. Therapeutic applications and potential mechanisms of acupuncture in migraine: a literature review and perspectives[J]. Front Neurosci, 2022, 16: 1022455.DOI: 10.3389/fnins.2022.1022455.
|
[8] |
Liu QQ, Yao XX, Gao SH, et al. Role of 5-HT receptors in neuropathic pain: potential therapeutic implications[J]. Pharmacol Res, 2020, 159: 104949. DOI: 10.1016/j.phrs.2020.104949.
|
[9] |
Munawar N, Bitar MS, Masocha W. Activation of 5-HT1A receptors normalizes the overexpression of presynaptic 5-HT1A receptors and alleviates diabetic neuropathic pain[J]. Int J Mol Sci, 2023, 24(18): 14334. DOI: 10.3390/ijms241814334.
|
[10] |
Yabut JM, Crane JD, Green AE, et al. Emerging roles for serotonin in regulating metabolism: new implications for an ancient molecule[J]. Endocr Rev, 2019, 40(4): 1092-1107. DOI: 10.1210/er.2018-00283.
|
[11] |
Abe N, Nishihara T, Yorozuya T, et al. Microglia and macrophages in the pathological central and peripheral nervous systems[J]. Cells, 2020, 9(9): 2132. DOI: 10.3390/cells9092132.
|
[12] |
Carrasco E, Gómez de Las Heras MM, Gabandé-Rodríguez E, et al. The role of T cells in age-related diseases[J]. Nat Rev Immunol,2022, 22(2): 97-111. DOI: 10.1038/s41577-021-00557-4.
|
[13] |
Bai R, Luo Y. Exploring the role of mitochondrial-associated and peripheral neuropathy genes in the pathogenesis of diabetic peripheral neuropathy[J]. BMC Neurol, 2024, 24(1): 95. DOI:10.1186/s12883-024-03589-0.
|
[14] |
Kang H. Sample size determination and power analysis using the G*power software[J]. J Educ Eval Health Prof, 2021, 18: 17. DOI:10.3352/jeehp.2021.18.17.
|
[15] |
Tesfaye S, Boulton AJ, Dyck PJ, et al. Diabetic neuropathies:update on definitions, diagnostic criteria, estimation of severity,and treatments[J]. Diabetes Care, 2010, 33(10): 2285-2293. DOI:10.2337/dc10-1303.
|
[16] |
Sherman BT, Hao M, Qiu J, et al. David: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)[J]. Nucleic Acids Res, 2022, 50(W1): W216-W221. DOI: 10.1093/nar/gkac194.
|
[17] |
Kawada JI, Takeuchi S, Imai H, et al. Immune cell infiltration landscapes in pediatric acute myocarditis analyzed by cibersort[J].J Cardiol, 2021, 77(2): 174-178. DOI: 10.1016/j.jjcc.2020.08.004.
|
[18] |
Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles[J]. Nat Methods, 2015,12(5): 453-457. DOI: 10.1038/nmeth.3337.
|
[19] |
Mokhtar N, Doly S, Courteix C. Diabetic neuropathic pain and serotonin: what is new in the last 15 years?[J]. Biomedicines,2023, 11(7): 1924. DOI: 10.3390/biomedicines11071924.
|
[20] |
Cai Y, Li X, Zhou H, et al. The serotonergic system dysfunction in diabetes mellitus[J]. Front Cell Neurosci, 2022, 16: 899069. DOI:10.3389/fncel.2022.899069.
|
[21] |
Choi W, Moon JH, Kim H. Serotonergic regulation of energy metabolism in peripheral tissues[J]. J Endocrinol, 2020, 245(1):R1-R10. DOI: 10.1530/joe-19-0546.
|
[22] |
Moon JH, Oh CM, Kim H. Serotonin in the regulation of systemic energy metabolism[J]. J Diabetes Investig, 2022, 13(10): 1639-1645. DOI: 10.1111/jdi.13879.
|
[23] |
Martin H, Bullich S, Guiard BP, et al. The impact of insulin on the serotonergic system and consequences on diabetes-associated mood disorders[J]. J Neuroendocrinol, 2021, 33(4): e12928. DOI:10.1111/jne.12928.
|
[24] |
Ishibashi F, Taniguchi M, Kosaka A, et al. Improvement in neuropathy outcomes with normalizing HbA1c in patients with type 2 diabetes[J]. Diabetes Care, 2019, 42(1): 110-118. DOI:10.2337/dc18-1560.
|
[25] |
Pinto MV, Rosa L, Pinto LF, et al. Hba1c variability and longterm glycemic control are linked to peripheral neuropathy in patients with type 1 diabetes[J]. Diabetol Metab Syndr, 2020, 12:85. DOI: 10.1186/s13098-020-00594-4.
|